Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 3-6, 2024 | San Diego, CA
October 17-18, 2023 | San Francisco, CA
October 23-25, 2023 | Washington, DC
November 13-15, 2023 | New Orleans, LA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.
BIO applauds FDA’s efforts to develop a plan consistent with PDUFA VII commitments and the FY23 Omnibus Bill and offers strategic recommendations.
.png){kind=logo}
BIO applauds FDA’s efforts to develop a plan consistent with PDUFA VII commitments and the FY23 Omnibus Bill and offers strategic recommendations.